Drug Shortage Report for FEIBA NF
| Report ID | 140472 |
| Drug Identification Number | 02202581 |
| Brand name | FEIBA NF |
| Common or Proper name | ANTI INHIBITOR COAGULANT COMPLEX |
| Company Name | TAKEDA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ANTI-INHIBITOR COAGULANT COMPLEX |
| Strength(s) | 1300UNIT |
| Dosage form(s) | KIT POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | Labelled 1000 U 50mL Vial |
| ATC code | B02BD |
| ATC description | VITAMIN K AND OTHER HEMOSTATICS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2021-06-04 |
| Actual start date | 2021-06-04 |
| Estimated end date | 2021-06-30 |
| Actual end date | 2021-06-18 |
| Shortage status | Resolved |
| Updated date | 2021-06-25 |
| Company comments | Resolved |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2021-06-25 | French | Compare |
| v4 | 2021-06-25 | English | Compare |
| v3 | 2021-06-05 | English | Compare |
| v2 | 2021-06-04 | French | Compare |
| v1 | 2021-06-04 | English | Compare |
Showing 1 to 5 of 5